Clinical Trial Update: MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate MitoQ for claudication in peripheral arterial disease, examining myofiber and micro-vessel pathology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• MitoQ

Snippet

Sponsor: University of Nebraska | Conditions: Peripheral Arterial Disease | NA | Status: RECRUITING